About SCRI

about SCRI

The Singapore Clinical Research Institute (SCRI) is the national academic research organisation dedicated to enhancing the standards of clinical research capabilities in Singapore. SCRI leads in scientific collaborations and research innovation to search for better treatment outcomes for our patients with our healthcare partners. Together, the nation is set to develop core capabilities and thought leadership for clinical research excellence.

With robust coordination abilities and infrastructure, SCRI is ready to advance Singapore in the field of clinical research for the coming years.

News and Workshops

Distinguished Contributor Award for CRCs 2022

Congratulations to the nine Clinical Research Coordinators (CRCs) who received the Distinguished Contributor Award for CRCs for their dedication to the profession and outstanding contributions to Singapore’s research community. Held on 11 January 2023, this is the third year the award has been presented since its launch in 2019, and there were 27 nominees received […]

SCRI Launches the Master Clinical Trials Agreement for clinical trials to begin sooner in Singapore

SCRI is pleased to launch the Master Clinical Trials Agreement (MCTA) at the Clinical Research Roundtable held on 15 November 2022. The MCTA provides a legal template that will shorten the initiation of clinical trials in Singapore by reducing the turnaround time in reviewing trial agreements between industry sponsors and public healthcare institutions. The template […]